These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
67 related articles for article (PubMed ID: 12197192)
1. Mutations in prothrombin and factor V genes do not contribute significantly to placental vasculopathy in a high-risk patient cohort in South Africa. Hillermann R; Gebhardt GS; Isaacs R; Steyn DW; Odendaal HJ S Afr Med J; 2002 Jul; 92(7):526-7. PubMed ID: 12197192 [No Abstract] [Full Text] [Related]
3. Frequency of selected thrombophilias in women with placental abruption. Procházka M; Lubuský M; Slavík L; Hrachovec P; Zielina P; Kudela M; Lindqvist PG Aust N Z J Obstet Gynaecol; 2007 Aug; 47(4):297-301. PubMed ID: 17627684 [TBL] [Abstract][Full Text] [Related]
4. Polymorphisms in various coagulation genes in black South African women with placental abruption. Hira B; Pegoraro RJ; Rom L; Govender T; Moodley J BJOG; 2002 May; 109(5):574-5. PubMed ID: 12066950 [TBL] [Abstract][Full Text] [Related]
5. Increased frequency of genetic thrombophilia in women with complications of pregnancy. Kupferminc MJ; Eldor A; Steinman N; Many A; Bar-Am A; Jaffa A; Fait G; Lessing JB N Engl J Med; 1999 Jan; 340(1):9-13. PubMed ID: 9878639 [TBL] [Abstract][Full Text] [Related]
6. Thrombophilic mutations are a main risk factor for placental abruption. Facchinetti F; Marozio L; Grandone E; Pizzi C; Volpe A; Benedetto C Haematologica; 2003 Jul; 88(7):785-8. PubMed ID: 12857557 [TBL] [Abstract][Full Text] [Related]
7. Prothrombin and factor V mutations in women with a history of thrombosis during pregnancy and the puerperium. Gerhardt A; Scharf RE; Beckmann MW; Struve S; Bender HG; Pillny M; Sandmann W; Zotz RB N Engl J Med; 2000 Feb; 342(6):374-80. PubMed ID: 10666427 [TBL] [Abstract][Full Text] [Related]
8. Prevalence of factor V G1691A (factor V-Leiden) and prothrombin G20210A gene mutations in a recurrent miscarriage population. Finan RR; Tamim H; Ameen G; Sharida HE; Rashid M; Almawi WY Am J Hematol; 2002 Dec; 71(4):300-5. PubMed ID: 12447960 [TBL] [Abstract][Full Text] [Related]
9. High prevalence of the prothrombin gene mutation in women with intrauterine growth retardation, abruptio placentae and second trimester loss. Kupferminc MJ; Peri H; Zwang E; Yaron Y; Wolman I; Eldor A Acta Obstet Gynecol Scand; 2000 Nov; 79(11):963-7. PubMed ID: 11081681 [TBL] [Abstract][Full Text] [Related]
11. Risk factors for clinical manifestations in carriers of Factor V Leiden and prothrombin gene mutations. DeSancho MT; Berlus N; Christos PJ; Rand J Blood Coagul Fibrinolysis; 2010 Jan; 21(1):11-5. PubMed ID: 19474699 [TBL] [Abstract][Full Text] [Related]
12. The risk of recurrent deep venous thrombosis among heterozygous carriers of both factor V Leiden and the G20210A prothrombin mutation. De Stefano V; Martinelli I; Mannucci PM; Paciaroni K; Chiusolo P; Casorelli I; Rossi E; Leone G N Engl J Med; 1999 Sep; 341(11):801-6. PubMed ID: 10477778 [TBL] [Abstract][Full Text] [Related]
13. Factor V Leiden and prothrombin gene G20210A mutation and in vitro fertilization: prospective cohort study. Ricci G; Bogatti P; Fischer-Tamaro L; Giolo E; Luppi S; Montico M; Ronfani L; Morgutti M Hum Reprod; 2011 Nov; 26(11):3068-77. PubMed ID: 21868400 [TBL] [Abstract][Full Text] [Related]
14. What clinical significance has the presence of the homozygous G20210A prothrombin gene mutation in a healthy woman? Martlew VJ; Perez-Casal M; Alfirevic Z; Toh CH Thromb Haemost; 2000 Aug; 84(2):355-6. PubMed ID: 10959715 [No Abstract] [Full Text] [Related]
15. Hereditary thrombophilia and recurrent pregnancy loss: a retrospective cohort study of pregnancy outcome and obstetric complications. Lund M; Nielsen HS; Hviid TV; Steffensen R; Nyboe Andersen A; Christiansen OB Hum Reprod; 2010 Dec; 25(12):2978-84. PubMed ID: 20937743 [TBL] [Abstract][Full Text] [Related]
16. The status of thrombophilic defects and non-O blood group as risk factors for gestational vascular complications among Tunisian women. Klai S; Fekih-Mrissa N; Rachdi R; Gritli N Acta Haematol; 2011; 125(3):115-20. PubMed ID: 21109732 [TBL] [Abstract][Full Text] [Related]
17. [Sucessful pregnancy outcome following three severe placental abruptions and intrauterine fetal death in the patient--heterozygous carrier of R506Q mutation of factor V (Leiden)]. Dimitrova V; Koleva R; Savov A; Chernev T; Khranov Iu; Georgiev G; Slŭncheva B; Raĭcheva S Akush Ginekol (Sofiia); 2004; 43(5):47-54. PubMed ID: 15518286 [TBL] [Abstract][Full Text] [Related]
18. Factor V Leiden and prothrombin 20210 G-A mutations in controls and in patients with thromboembolic events during pregnancy or the puerperium. Yilmazer M; Kurtay G; Sonmezer M; Akar N Arch Gynecol Obstet; 2003 Oct; 268(4):304-8. PubMed ID: 14504875 [TBL] [Abstract][Full Text] [Related]
20. Factor V Leiden and prothrombin gene 20210A variant in neonatal thromboembolism and in healthy neonates and adults: a study in a single center. Atasay B; Arsan S; Günlemez A; Kemahli S; Akar N Pediatr Hematol Oncol; 2003 Dec; 20(8):627-34. PubMed ID: 14578033 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]